Antihyperlipidemic combinations 

Antihyperlipidemic agents promote reduction of lipid levels in the blood. Some antihyperlipidemic agents aim to lower the levels of low-density lipoprotein (LDL) cholesterol, some reduce triglyceride levels, and some help raise the high-density lipoprotein (HDL) cholesterol. By reducing the LDL cholesterol, they can prevent both the primary and secondary symptoms of coronary heart disease.

Niacin and ezetimibe are available in combination with statins, as single dose forms. Antihyperlipidemic agents are also available in combinations with antihypertensive agents. By having one pill with a couple of agents makes it easier to take and increases compliance.

Several drug combinations are available for the treatment of combined hyperlipidemia (elevated LDL-C and elevated triglycerides, generally with concurrent low HDL-C). Statins plus niacin have been successfully used in this setting, as have statin plus fibrate and statin plus fish oil combinations.

Ezetimibe and atorvastatin combination is used together with a proper diet to treat high cholesterol and triglyceride (fats) levels in the blood.